(Q28168105)

7 January 2021

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

1 reference

7 January 2021

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Alzheimer disease as a vascular disorder: nosological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Silent brain infarcts and the risk of dementia and cognitive decline.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Cerebral microvascular pathology in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

The cholesterol controversy is over. Why did it take so long?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

The role of cholesterol in the biosynthesis of beta-amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Anti-atherogenic effects of the acyl-CoA:cholesterol acyltransferase inhibitor, avasimibe (CI-1011), in cultured primary human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Oxidized phospholipids and isoprostanes in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Microglia: Intrinsic immuneffector cell of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

In-vivo measurement of activated microglia in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Apolipoprotein E Alleles and Risk of Coronary Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Vascular inflammation and the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Angiotensin II receptor subtypes in the human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Angiotensin II inhibits cortical cholinergic function: implications for cognition.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Platelets are the primary source of amyloid beta-peptide in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Platelet phagocytosis and processing of beta-amyloid precursor protein as a mechanism of macrophage activation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Secreted forms of the amyloid-beta precursor protein are ligands for the class A scavenger receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Platelets in atherosclerosis: a new role for beta-amyloid peptide beyond Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

eLiXiRs for restraining inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Reciprocal regulation of inflammation and lipid metabolism by liver X receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Accumulation of foam cells in liver X receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Identification of macrophage liver X receptors as inhibitors of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Atherosclerosis and angiogenesis. Its pathophysiological significance in humans as well as in an animal model induced by the gene transfer of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Oncostatin M induces angiogenesis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Vascular endothelial growth factor enhances atherosclerotic plaque progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Alzheimer's disease and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Microvessels from Alzheimer's disease brains kill neurons in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Current perspectives on statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Statins and the risk of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Statins and neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Neuroprotective properties of statins in cerebral ischemia and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

An 18-year follow-up of overweight and risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2915900-X

7 January 2021

10.1016/S0140-6736(04)15900-X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

319879

319879

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference